Intravascular Ultrasound Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Fahed Darmoch, M Chadi Alraies, Yasser Al-Khadra...
https://pubmed.ncbi.nlm.nih.gov/32075491/Actively Recruiting
Led by SUK MIN SEO · Updated on 2026-04-06
1500
Participants Needed
1
Research Sites
52 weeks
Total Duration
Coronary artery disease causes significant illness and death worldwide. This trial compares two methods of guiding percutaneous coronary intervention PCI in patients with acute coronary syndrome ACS. Researchers are evaluating whether using intravascular ultrasound IVUS for PCI offers better clinical outcomes than the standard angiography guidance. The study is a prospective, multicenter, randomized controlled trial involving 1,500 participants from 15 centers in Korea, focusing on target vessel failure over two years. Participants will be randomly assigned to one of two groups PCI guided by IVUS or PCI guided by coronary angiography. In the IVUS group, ultrasound will be used before, during, and after stent placement to optimize the procedure, with mandatory post-stent assessment and possible additional treatments if needed. The angiography group will receive PCI guided by standard angiography without routine IVUS use, although IVUS may be used in bailout situations. Both groups will receive drug-eluting stents appropriate for their coronary lesions. During the study, participants will be monitored for two years for outcomes such as target vessel failure, cardiac events, and procedural measures. Assessments include clinical follow-up, angiographic evaluation, and monitoring for complications like stent thrombosis and kidney injury after contrast use. The study aims to gather detailed data on the safety and effectiveness of IVUS-guided PCI compared to angiography-guided PCI in ACS patients.
CONDITIONS
IVUS-Guided vs Angiography-Guided PCI in Acute Coronary Syndrome
S
SUK MIN SEO, Assisted Professor
Y
YUN JU KANG, RN,CRC
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
SUK MIN SEO
Lead Sponsor
Boston Scientific Korea Co. Ltd
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single procedure with periprocedural care
Participants undergo percutaneous coronary intervention (PCI) guided either by intravascular ultrasound (IVUS) or conventional coronary angiography to implant drug-eluting stents. Optimization of stent placement is performed according to the assigned guidance method.
1 procedure visit (in-person)
Duration - 24 months
Participants are monitored for clinical outcomes related to the procedure and coronary artery disease, including target vessel failure and cardiac events, over a period of 24 months after the intervention.
Regular follow-up visits over 24 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Fahed Darmoch, M Chadi Alraies, Yasser Al-Khadra...
https://pubmed.ncbi.nlm.nih.gov/32075491/F Schiele, N Meneveau, A Vuillemenot...
https://pubmed.ncbi.nlm.nih.gov/9708456/SUK MIN SEO
Lead Sponsor
Boston Scientific Korea Co. Ltd
Collaborating Sponsor